Read more

August 10, 2020
1 min read
Save

Prokera Slim approved for use in Taiwan

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Bio-Tissue announced the approval of the Prokera Slim corneal bandage for use by eye care professionals in Taiwan.

The Prokera Slim is a low-profile amniotic membrane corneal bandage that contours to the ocular surface to improve comfort and long-term outcomes during healing processes, according to a press release.

Prokera was cleared by the FDA in 2003. It contains cryopreserved amniotic membrane that acts in anti-inflammatory, anti-scarring and anti-angiogenic capacities on the ocular surface.

“Clinical research has shown us that 70% of eyes re-epithelialized by day 5 with Prokera Slim vs. only 20% with a bandage contact lens. Additionally, 90% of eyes achieved absolute corneal clarity by day 7 with Prokera Slim vs. 0% with a bandage contact lens. That is significant for clinical and patient outcomes,” Scheffer Tseng, MD, PhD, co-founder and chief technology officer at Bio-Tissue, said in the release.

The product is distributed by Orient EuroPharma in Taiwan.